The Transmission and Fitness of Drug Resistant HIV-1
耐药 HIV-1 的传播和适应性
基本信息
- 批准号:7892053
- 负责人:
- 金额:$ 55.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAmino Acid SubstitutionAnti-Retroviral AgentsAntiretroviral drug resistanceAntiretroviral resistanceAttentionBerryCase StudyClinicalDNADrug Delivery SystemsDrug resistanceFailureFundingGeneticGenomeGrowthHIVHIV-1HIV-1 drug resistanceIn VitroIndividualInfectionIntegraseIntegrase InhibitorsInterruptionKineticsLinkMolecular CloningMonitorMulti-Drug ResistanceMutationPathogenicityPatientsPatternPeer ReviewPeptide HydrolasesPharmaceutical PreparationsPlanet MarsPrevalenceProtease InhibitorPublic HealthPublicationsRNA-Directed DNA PolymeraseResearch PersonnelResistanceReverse Transcriptase InhibitorsRiskSerial PassageSyphilisT-20TechnologyTestingTherapeuticToxic effectTreatment ProtocolsUnited States National Institutes of HealthVaccinationVariantViralViremiaVirusVirus Inhibitorsantiretroviral therapybasecostdrug resistant virusexperiencefitnessnon-nucleoside reverse transcriptase inhibitorsnoveloutcome forecastparkin gene/proteinpillprogramstransmission process
项目摘要
The transmission of drug resistant HIV-1 represents a significant challenge to the public health as well as the
treatment and prognosis of an HIV-1 infected individual. Treatment options for HIV-1 infection have evolved
over the past 10 years such that many newly infected patients can be treated with as few as 2 pills taken
once daily with acceptable short term and long term toxicities. However for many individuals simplified
regimens are not an option due to the acquisition of drug resistant HIV-1. Furthermore, unlike drug resistant
viruses in chronically infected individuals who discontinue therapy, transmitted drug resistant viruses persist
in the newly infected host for years in the absence of treatment, increasing the risk of transmission to a
susceptible host. Indeed, increases in the transmission of viruses resistant to one, two or even three classes
of drugs have been documented over the past decade. The objectives of this proposal are three-fold; 1. To
continue to monitor for the prevalence of drug resistant transmissions with attention not only to traditional
targets such as reverse transcriptase (RT) and protease (Pr), but to include newer drug targets such as viral
envelope and integrase; 2. To understand the potential for transmission of viruses resistant to inhibitors of
RT, Pr and novels agents such as integrase inhibitors; 3. To understand mechanisms by which MDR viruses
compensate for mutations in RT and Pr, that confer high level resistance and yet allow for transmission. To
accomplish these aims we will continue to identify newly HIV-1 infected individuals and use PCR technology
to sequence relevant portions of the HIV-1 genome. Those viruses harboring drug resistant conferring amino
acid substitutions will be tested for phenotypic resistance to specific agents. Using infectious molecular
clones constructed from a panel of transmitted MDR HIV-1 viruses we will generate viruses resistant to
integrase inhibitors by serial in vitro passage for in depth characterization with the underlying hypothesis that
viruses with the potential for transmission must retain replication kinetics approximating that of wild type
viruses. Finally, chimeric viruses will be constructed using infectious molecular clones to understand viral
determinants by which MDR viruses compensate for predicted fitness loss thereby maintaining replication
capacity, transmissiblity and pathogenicity.
具有抗药性的艾滋病毒-1的传播对公共卫生以及
1例HIV-1感染者的治疗和预后。HIV-1感染的治疗选择已经演变
在过去的10年里,许多新感染的患者只需服用2片就可以得到治疗
每日一次,短期和长期毒性均可接受。然而,对于许多人来说,简化了
由于感染了具有抗药性的HIV-1,方案不是一个选择。此外,与抗药性不同
停止治疗的慢性感染者中的病毒,传播的耐药病毒持续存在
在新感染的宿主多年没有治疗的情况下,增加了传播到
易感宿主。事实上,对一类、两类甚至三类耐药病毒的传播增加
在过去的十年里已经被记录在案。这项建议的目标有三个:1.
继续监测耐药传播的流行情况,不仅关注传统的
靶点如逆转录酶(RT)和蛋白酶(PR),但包括较新的药物靶点,如病毒
包膜和整合酶;2.了解耐药病毒的传播潜力
RT、PR和整合酶抑制剂等新药;3.了解MDR病毒的作用机制
补偿RT和PR的突变,这些突变赋予高水平的抵抗力,但仍允许传播。至
为了达到这些目标,我们将继续识别新的HIV-1感染者,并使用聚合酶链式反应技术
对HIV-1基因组的相关部分进行测序。那些含有抗药性赋予氨基的病毒
酸替代将测试对特定试剂的表型抗性。使用具有传染性的分子
从一组传播的MDR HIV-1病毒构建的克隆,我们将产生抗药性的病毒
整合酶抑制剂通过体外连续传代进行深入表征,其基本假设是
具有传播潜力的病毒必须保持与野生型接近的复制动力学
病毒。最后,将使用具有感染性的分子克隆来构建嵌合病毒以了解病毒
MDR病毒补偿预测的适应度损失从而维持复制的决定因素
能力、传播性和致病性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin H Markowitz其他文献
Martin H Markowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin H Markowitz', 18)}}的其他基金
A preclinical assessment of monthly intramuscular GSK1265744, an InSTI, as PrEP
每月肌肉注射 GSK1265744(一种 InSTI)作为 PrEP 的临床前评估
- 批准号:
8681345 - 财政年份:2012
- 资助金额:
$ 55.57万 - 项目类别:
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
HIV 和注射吸毒者免疫激活增加的相关性和后果
- 批准号:
9040131 - 财政年份:2012
- 资助金额:
$ 55.57万 - 项目类别:
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
HIV 和注射吸毒者免疫激活增加的相关性和后果
- 批准号:
8458527 - 财政年份:2012
- 资助金额:
$ 55.57万 - 项目类别:
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
HIV 和注射吸毒者免疫激活增加的相关性和后果
- 批准号:
8637966 - 财政年份:2012
- 资助金额:
$ 55.57万 - 项目类别:
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
HIV 和注射吸毒者免疫激活增加的相关性和后果
- 批准号:
8321738 - 财政年份:2012
- 资助金额:
$ 55.57万 - 项目类别:
SAFETY AND ANTIVIRAL ACTIVITY OF 3 MONOCLONAL ANTIBODIES IN HIV
3 种单克隆抗体在 HIV 中的安全性和抗病毒活性
- 批准号:
7207026 - 财政年份:2005
- 资助金额:
$ 55.57万 - 项目类别:
ACUTE HIV INFECTION & EARLY DISEASE RESEARCH PROGRAM (AIEDRP)
急性艾滋病毒感染
- 批准号:
7207020 - 财政年份:2005
- 资助金额:
$ 55.57万 - 项目类别:
AN OBSERVATIONAL STUDY OF TREATED AND UNTREATED ACUTE AND EARLY HIV-1 INFECTION
对治疗和未治疗的急性和早期 HIV-1 感染的观察性研究
- 批准号:
7207004 - 财政年份:2005
- 资助金额:
$ 55.57万 - 项目类别:
VIRAL AND HOST FACTORS IN THE TRANSMISSION AND PATHOGENESIS OF HIV
HIV 传播和发病机制中的病毒和宿主因素
- 批准号:
7207002 - 财政年份:2005
- 资助金额:
$ 55.57万 - 项目类别:
相似海外基金
Phenotypic consequences of a modern human-specific amino acid substitution in ADSL
ADSL 中现代人类特异性氨基酸取代的表型后果
- 批准号:
24K18167 - 财政年份:2024
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Estimation of stability and functional changes due to amino acid substitution using molecular simulations
使用分子模拟估计氨基酸取代引起的稳定性和功能变化
- 批准号:
20H03230 - 财政年份:2020
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanisms of prion protein conversion caused by an amino acid substitution in glycosylphosphatidylinositol anchoring signal peptide
阐明糖基磷脂酰肌醇锚定信号肽中氨基酸取代引起的朊病毒蛋白转化机制
- 批准号:
16K18790 - 财政年份:2016
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Amino acid substitution without genetic modification
无需基因改造的氨基酸替代
- 批准号:
15H05491 - 财政年份:2015
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Study on PSII hydrogen bond networks by exhaustive amino acid substitution
穷举氨基酸取代研究PSII氢键网络
- 批准号:
15K07110 - 财政年份:2015
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the effect of HCV propagationa and IFN sensitivity by amino acid substitution in interferon sensitivity-determining region.
阐明干扰素敏感性决定区氨基酸取代对 HCV 传播和干扰素敏感性的影响。
- 批准号:
26860309 - 财政年份:2014
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The analysis of the restriction of amino acid substitution on the hemagglutinin molecule of influenza A virus
甲型流感病毒血凝素分子氨基酸取代限制性分析
- 批准号:
14370104 - 财政年份:2002
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Changes in the Substrate Specificities of Farnesyl Diphosphate Synthase by a Single Amino Acid Substitution
单一氨基酸取代对法尼基二磷酸合酶底物特异性的变化
- 批准号:
12680587 - 财政年份:2000
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of the Relationship between Amino Acid Substitution and Phenotype of the Tail Sheath Protein of Bacteriophage T4
噬菌体T4尾鞘蛋白氨基酸取代与表型关系分析
- 批准号:
02680125 - 财政年份:1990
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Hypothesis: Both appearance and disappearance of viruses are controlled by the accumulation of amino acid substitution in receptor binding domain
假设:病毒的出现和消失都是由受体结合域氨基酸取代的积累控制的
- 批准号:
02454184 - 财政年份:1990
- 资助金额:
$ 55.57万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)